Group structure
23 companies in 19 countries
Loading your page…
Loading your page…
23 companies in 19 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 278
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABREVA10% · Cream | Docosanol | United States | Marketed | 2000 |
| ADVIL200mg base · Tablet | Ibuprofen | United States | Marketed | 2012 |
| ADVIL200mg · Tablet | Ibuprofen | United States | Marketed | 1984 |
| ADVIL 12 HOUR600 mg · Tablet (Extended-Release) | Ibuprofen | Canada | Marketed | 2016 |
| ADVIL ALLERGY AND CONGESTION RELIEF4mg; 200mg; 10mg · Tablet | Chlorpheniramine, Ibuprofen, Phenylephrine | United States | Marketed | 2011 |
| ADVIL ALLERGY SINUS2mg; 200mg; 30mg · Tablet | Chlorpheniramine, Ibuprofen, Pseudoephedrine | United States | Marketed | 2002 |
| ADVIL ARTHRITIS PAIN400 mg · Capsule | Ibuprofen | Canada | Marketed | 2014 |
| ADVIL BACK PAIN200 mg + 500 mg · Tablet | Ibuprofen, Methocarbamol | Canada | Authorised | |
| ADVIL CAPLETS200 mg · Tablet | Ibuprofen | Canada | Marketed | 1992 |
| ADVIL COLD AND SINUS200mg free acid and potassium salt; 30mg · Capsule | Ibuprofen, Salt, Pseudoephedrine | United States | Marketed | 2002 |
| ADVIL COLD AND SINUS200mg; 30mg · Tablet | Ibuprofen, Pseudoephedrine | United States | Marketed | 1989 |
| ADVIL COLD AND SINUS200 mg + 30 mg · Tablet | Ibuprofen, Pseudoephedrine | Canada | Marketed | 1993 |
| ADVIL COLD AND SINUS DAYTIME200 mg + 30 mg · Tablet | Ibuprofen, Pseudoephedrine | Canada | Marketed | 2006 |
| ADVIL COLD AND SINUS NIGHTTIME2 mg + 200 mg + 30 mg · Tablet | Chlorpheniramine, Ibuprofen, Pseudoephedrine | Canada | Marketed | 2006 |
| ADVIL COLD & SINUS CONVENIENCE PACK2 mg + 200 mg + 200 mg + 30 mg + 30 mg · Kit, Tablet | Chlorpheniramine, Ibuprofen, Pseudoephedrine | Canada | Marketed | 2014 |
| ADVIL COLD & SINUS EXTRA STRENGTH LIQUI-GELS400 mg + 60 mg · Capsule | Ibuprofen, Pseudoephedrine | Canada | Authorised | |
| ADVIL COLD, SINUS & FLU EXTRA STRENGTH4 mg + 400 mg + 60 mg · Tablet | Chlorpheniramine, Ibuprofen, Pseudoephedrine | Canada | Marketed | 2018 |
| ADVIL COLD & SINUS LIQUI-GELS200 mg + 30 mg · Capsule | Ibuprofen, Pseudoephedrine | Canada | Marketed | 2005 |
| ADVIL COLD & SINUS PLUS2 mg + 200 mg + 30 mg · Tablet | Chlorpheniramine, Ibuprofen, Pseudoephedrine | Canada | Marketed | 2004 |
| ADVIL CONGESTION RELIEF200mg; 10mg · Tablet | Ibuprofen, Phenylephrine | United States | Marketed | 2010 |
| Advil, dragees 200 mgOmhulde tablet | Ibuprofen | Netherlands | Authorised | 1987 |
| ADVIL DUAL ACTION WITH ACETAMINOPHEN250mg; 125mg · Tablet | Paracetamol, Ibuprofen | United States | Marketed | 2020 |
| ADVIL EXTRA STRENGTH CAPLETS400 mg · Tablet | Ibuprofen | Canada | Marketed | 2002 |
| ADVIL EXTRA STRENGTH LIQUI-GELS400 mg · Capsule | Ibuprofen | Canada | Marketed | 2004 |
| ADVIL FLU25 mg + 200 mg · Capsule | Diphenhydramine, Ibuprofen | Canada | Marketed | 2013 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 106 | 101 | 5 | CompaniesAll medicines |
| Netherlands | 35 | 35 | 0 | CompaniesAll medicines |
| United States | 33 | 33 | 0 | CompaniesAll medicines |
| Spain | 32 | 27 | 5 | CompaniesAll medicines |
| Singapore | 29 | 29 | 0 | CompaniesAll medicines |
| Italy | 24 | 24 | 0 | CompaniesAll medicines |
| Croatia | 17 | 17 | 0 | CompaniesAll medicines |
| European Union (EMA) | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of France, Serbia, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licence: Norwegian Licence for Open Government Data
Oficiul Național al Registrului Comerțului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Register právnických osôb, podnikateľov a orgánov verejnej moci; public API licence names Štatistický úrad Slovenskej republiky; administration transferred to Ministerstvo vnútra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Licence: Creative Commons Attribution
Slovak Ministry of Finance, Register účtovných závierok (RÚZ) Open API; exact IČO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Licence: CC0
Report an error or request removalCorrections from the company itself are welcome.